Analysis and Commentary STEVEN GROSSMAN 2/5/16 Analysis and Commentary STEVEN GROSSMAN 2/5/16 Hunting for the Wheat in the Chaff of Hyperbole Read More Advocacy at a Glance STEVEN GROSSMAN 2/5/16 Advocacy at a Glance STEVEN GROSSMAN 2/5/16 Obama-Proposed “Cancer Moonshot” Includes Monies for FDA Read More Analysis and Commentary STEVEN GROSSMAN 1/29/16 Analysis and Commentary STEVEN GROSSMAN 1/29/16 The Prompt Confirmation of a New Commissioner Read More Advocacy at a Glance STEVEN GROSSMAN 1/29/16 Advocacy at a Glance STEVEN GROSSMAN 1/29/16 Senator Murray Wants FDA at “Full Throttle;” Pushes Mandatory FDA Funding and more Read More Analysis and Commentary STEVEN GROSSMAN 1/23/16 Analysis and Commentary STEVEN GROSSMAN 1/23/16 Why Have We Watched "Cures" So Closely? Read More Advocacy at a Glance STEVEN GROSSMAN 1/23/16 Advocacy at a Glance STEVEN GROSSMAN 1/23/16 Federal Deficit Certain to Grow Over Next 10 Years and more Read More Analysis and Commentary STEVEN GROSSMAN 1/15/16 Analysis and Commentary STEVEN GROSSMAN 1/15/16 A Thank You ... and Now on to FY 17 Read More Advocacy at a Glance STEVEN GROSSMAN 1/15/16 Advocacy at a Glance STEVEN GROSSMAN 1/15/16 FY 17 Appropriations Process to Be Speeded Up and more Read More Analysis and Commentary STEVEN GROSSMAN 1/8/16 Analysis and Commentary STEVEN GROSSMAN 1/8/16 The Demonstration of Accountability to Multiple Stakeholders Read More Advocacy at a Glance STEVEN GROSSMAN 1/8/16 Advocacy at a Glance STEVEN GROSSMAN 1/8/16 FY17 Appropriations Process Begins Read More Analysis and Commentary STEVEN GROSSMAN 12/18/15 Analysis and Commentary STEVEN GROSSMAN 12/18/15 And Now for FY 17 -- Starting January 12 Read More Advocacy at a Glance STEVEN GROSSMAN 12/18/15 Advocacy at a Glance STEVEN GROSSMAN 12/18/15 FY 16 Appropriations Nears Finale and more Read More Uncategorized STEVEN GROSSMAN 12/18/15 Uncategorized STEVEN GROSSMAN 12/18/15 FDA Appropriation for FY 16 -- Center by Center Detail Read More Uncategorized STEVEN GROSSMAN 12/16/15 Uncategorized STEVEN GROSSMAN 12/16/15 FDA Gets $132 Million Over FY 15 Appropriation for FY 16 Read More Analysis and Commentary STEVEN GROSSMAN 12/11/15 Analysis and Commentary STEVEN GROSSMAN 12/11/15 And Still We Hold Our Breath in Hope Read More Advocacy at a Glance STEVEN GROSSMAN 12/11/15 Advocacy at a Glance STEVEN GROSSMAN 12/11/15 Senate HELP Committee Vote on FDA Commissioner Nomination Possible in January and more Read More Analysis and Commentary STEVEN GROSSMAN 12/4/15 Analysis and Commentary STEVEN GROSSMAN 12/4/15 When Can You "Show Me the Money"? Read More Advocacy at a Glance STEVEN GROSSMAN 12/4/15 Advocacy at a Glance STEVEN GROSSMAN 12/4/15 Appropriations Riders May Target Food Labeling and more Read More Analysis and Commentary STEVEN GROSSMAN 11/20/15 Analysis and Commentary STEVEN GROSSMAN 11/20/15 Of News, No News, and the Fine Art of Salmon Policy Riders Read More Advocacy at a Glance STEVEN GROSSMAN 11/20/15 Advocacy at a Glance STEVEN GROSSMAN 11/20/15 Califf Hearing Appears to Have Gone Well and more Read More Newer Posts Older Posts
Analysis and Commentary STEVEN GROSSMAN 2/5/16 Analysis and Commentary STEVEN GROSSMAN 2/5/16 Hunting for the Wheat in the Chaff of Hyperbole Read More
Advocacy at a Glance STEVEN GROSSMAN 2/5/16 Advocacy at a Glance STEVEN GROSSMAN 2/5/16 Obama-Proposed “Cancer Moonshot” Includes Monies for FDA Read More
Analysis and Commentary STEVEN GROSSMAN 1/29/16 Analysis and Commentary STEVEN GROSSMAN 1/29/16 The Prompt Confirmation of a New Commissioner Read More
Advocacy at a Glance STEVEN GROSSMAN 1/29/16 Advocacy at a Glance STEVEN GROSSMAN 1/29/16 Senator Murray Wants FDA at “Full Throttle;” Pushes Mandatory FDA Funding and more Read More
Analysis and Commentary STEVEN GROSSMAN 1/23/16 Analysis and Commentary STEVEN GROSSMAN 1/23/16 Why Have We Watched "Cures" So Closely? Read More
Advocacy at a Glance STEVEN GROSSMAN 1/23/16 Advocacy at a Glance STEVEN GROSSMAN 1/23/16 Federal Deficit Certain to Grow Over Next 10 Years and more Read More
Analysis and Commentary STEVEN GROSSMAN 1/15/16 Analysis and Commentary STEVEN GROSSMAN 1/15/16 A Thank You ... and Now on to FY 17 Read More
Advocacy at a Glance STEVEN GROSSMAN 1/15/16 Advocacy at a Glance STEVEN GROSSMAN 1/15/16 FY 17 Appropriations Process to Be Speeded Up and more Read More
Analysis and Commentary STEVEN GROSSMAN 1/8/16 Analysis and Commentary STEVEN GROSSMAN 1/8/16 The Demonstration of Accountability to Multiple Stakeholders Read More
Advocacy at a Glance STEVEN GROSSMAN 1/8/16 Advocacy at a Glance STEVEN GROSSMAN 1/8/16 FY17 Appropriations Process Begins Read More
Analysis and Commentary STEVEN GROSSMAN 12/18/15 Analysis and Commentary STEVEN GROSSMAN 12/18/15 And Now for FY 17 -- Starting January 12 Read More
Advocacy at a Glance STEVEN GROSSMAN 12/18/15 Advocacy at a Glance STEVEN GROSSMAN 12/18/15 FY 16 Appropriations Nears Finale and more Read More
Uncategorized STEVEN GROSSMAN 12/18/15 Uncategorized STEVEN GROSSMAN 12/18/15 FDA Appropriation for FY 16 -- Center by Center Detail Read More
Uncategorized STEVEN GROSSMAN 12/16/15 Uncategorized STEVEN GROSSMAN 12/16/15 FDA Gets $132 Million Over FY 15 Appropriation for FY 16 Read More
Analysis and Commentary STEVEN GROSSMAN 12/11/15 Analysis and Commentary STEVEN GROSSMAN 12/11/15 And Still We Hold Our Breath in Hope Read More
Advocacy at a Glance STEVEN GROSSMAN 12/11/15 Advocacy at a Glance STEVEN GROSSMAN 12/11/15 Senate HELP Committee Vote on FDA Commissioner Nomination Possible in January and more Read More
Analysis and Commentary STEVEN GROSSMAN 12/4/15 Analysis and Commentary STEVEN GROSSMAN 12/4/15 When Can You "Show Me the Money"? Read More
Advocacy at a Glance STEVEN GROSSMAN 12/4/15 Advocacy at a Glance STEVEN GROSSMAN 12/4/15 Appropriations Riders May Target Food Labeling and more Read More
Analysis and Commentary STEVEN GROSSMAN 11/20/15 Analysis and Commentary STEVEN GROSSMAN 11/20/15 Of News, No News, and the Fine Art of Salmon Policy Riders Read More
Advocacy at a Glance STEVEN GROSSMAN 11/20/15 Advocacy at a Glance STEVEN GROSSMAN 11/20/15 Califf Hearing Appears to Have Gone Well and more Read More
